Pembrolizumab as first-line treatment for metastatic uveal melanoma

Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

(2018) Richard D. Carvajal et al.   JOURNAL OF CLINICAL ONCOLOGY

Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma

(2018) Pablo Zoroquiain et al.   MODERN PATHOLOGY

Oncogenic signaling in uveal melanoma

(2018) John J. Park et al.   Pigment Cell & Melanoma Research

Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors

(2018) Manuel Rodrigues et al.   Nature Communications

Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition

(2017) Markus V. Heppt et al.   EUROPEAN JOURNAL OF CANCER

PD-L1 expression in tumor metastasis is different between uveal melanoma and cutaneous melanoma

(2017) Asad Javed et al.   Immunotherapy

Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy

(2017) Giovanni Schinzari et al.   MELANOMA RESEARCH

Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies

(2017) Kimberly M. Komatsubara et al.   Current Oncology Reports

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

(2016) Alain P. Algazi et al.   CANCER

Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

(2016) Amanda R Moore et al.   NATURE GENETICS

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

(2016) Ioannis Karydis et al.   OncoImmunology

Pembrolizumab versus Ipilimumab in Advanced Melanoma

(2015) Caroline Robert et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

(2015) Lisa Zimmer et al.   PLoS One

Single Nucleotide Polymorphism Array Analysis of Uveal Melanomas Reveals That Amplification of CNKSR3 Is Correlated With Improved Patient Survival

(2013) Sarah L. Lake et al.   AMERICAN JOURNAL OF PATHOLOGY

Metastatic melanoma to the liver: A contemporary and comprehensive review of surgical, systemic, and regional therapeutic options

(2013) Sanjiv S. Agarwala et al.   CANCER

Ipilimumab activity in advanced uveal melanoma

(2012) Muhammad Adnan Khattak et al.   MELANOMA RESEARCH

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy

(2011) Riccardo Danielli et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma

(2010) Jo Eyles et al.   JOURNAL OF CLINICAL INVESTIGATION